Имя ему СПИД: Четвертый всадник Апокалипсиса

Тарантул Вячеслав Залманович

Este J. A. Virus entry as a target for anti-HIV intervention // Curr. Med. Chem. 2003. Vol. 10. P. 1617–1632.

Gallo R. C. and Montagnier L. The discovery of HIV as the cause of AIDS // New Engl. J. Med. 2003.Vol. 349. P. 2283–2285.

Hecht F. M. et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection // AIDS. 2002. Vol. 16. P. 1119–1129.

C. Hoffmann and B. S. Kamps. (eds.). HIV Medicine 2003. Flying Publisher, 2003.

Krayevsky A. A., Watanabe K. A. Modified nucleosides as anti-aids drugs // Current Status and Perspectives. Moscow: Bioinform,1993.

McCune F M. The dynamics of CD4+ T-cell depletion in HIV disease // Nature. 2001. Vol. 410. P. 974–979.

McMichael A., Rowland-Jones S. L. Cellular immune responses to HIV // Nature. 2001. Vol. 410. P. 980–987.

Nabel G. Challenges and opportunities for development of an AIDS vaccine // Nature. 2001. Vol. 410. P. 1002–1007.

O'Brien S.Nelson G. W. Human genes that limit AIDS // Nature Genetics. 2004. Vol. 36. P. 565–574.

Piot P., Bartos M., Ghys P. D., Walker N. and Schwartliinder B. The global impact of HIV/AIDS // Nature. 2001. Vol. 410. P. 968–973.

Richman D. D. HIV chemotherapy // Nature. 2001. Vol. 410. P. 995– 1001.

Stevenson M. Dissecting HIV-1 through RNA interference // Nature Rev. Immunol. 2003. Vol. 3. P. 851–858. Stratov F, DeRose R., Purcell D. F., Kent S. Vaccines and vaccine strategies against HIV // Curr. Drug Targets. 2004. Vol. 5.P. 71–88.

StebbingGazzard B., Douek D. C. Where does HIV live? // New Eng. J. Medicine. 2004. Vol. 350. P. 1872–1880.

Tarantul V. Z. Transgenic mice as an in vivo model of lymphomagenesis // Int. Rev. Cytology. 2004. Vol. 236. P. 123–180.

Weiss R. A. Gulliver's travels in HIVland // Nature. 2001. Vol. 410. P. 963–967.

При

подготовке книги использованы также некоторые материалы Интернет-порталов AIDS.ru, SPID.ru и agat.aorta.ru.